When people think of clinical trials, they often picture new drugs or treatment regimens being tested directly on patients. Not all clinical trials involve testing an experimental therapy. Some focus instead on carefully observing patients and gathering information to better understand a disease.

These are known as observational clinical trials, and they play a valuable role in research of the rare cancer known as mesothelioma.

What Are Observational Clinical Trials?

Observational clinical trials, sometimes called epidemiological or natural history studies, do not involve testing or analyzing the efficacy of an experimental treatment. Instead, researchers follow patients over time, collecting data about their medical history, lifestyle, treatments received outside the trial, and how the disease progresses.

Unlike trials that test a new treatment, patients in observational clinical studies are not assigned to receive a specific therapy. Instead, doctors record and analyze outcomes from real-world care, helping scientists understand patterns that might guide future therapies.

Why Are They Important?

Observational trials are important for several reasons:

Understanding disease progression – They can show how mesothelioma and other types of cancer behave over time and what factors influence survival.
Identifying risk factors – They may reveal how age, occupation, exposure to asbestos or other toxins, or other conditions affect outcomes.
Improving future treatments – Data gathered can inform the design of treatment trials by highlighting unmet needs or patient subgroups that respond differently.
Quality of life insights – These studies may uncover how treatments impact daily living, which can shape supportive care approaches.

Priorities in Observational Clinical Trials

While they don’t test new drugs directly, observational clinical trials aim to:

Collect detailed patient data in real-world conditions
Study long-term safety of already-approved treatments
Track health outcomes across diverse patient groups
Generate hypotheses that can be tested in later interventional trials

Efficacy vs. Safety in Observational Medical Trials

Unlike treatment clinical trials, efficacy and safety aren’t measured in observational studies through experimental drugs. Instead, observational trials look at the effectiveness and side effects of existing treatments in everyday practice, outside of tightly controlled trial settings. This provides a more realistic picture of patient experiences.

Examples in Mesothelioma

While clinical trials for mesothelioma focusing on observation are less common than studies testing a specific treatment, they do exist. Examples include:

Natural history studies of mesothelioma patients, which follow disease progression without altering treatment
Registry-based studies, where patient information from cancer registries or hospital databases is analyzed to understand survival trends or treatment patterns
Quality-of-life surveys, which document the impact of surgery, chemotherapy or immunotherapy on patients’ day-to-day lives
Occupational exposure studies, where people working in jobs at high risk of asbestos exposure (the only cause of mesothelioma) are followed to determine their amount of asbestos exposure, whether they develop mesothelioma, and how long it takes them to be diagnosed

These studies may not test new therapies directly, but they provide essential knowledge that shapes the way clinical researchers design future interventions.

Final Thoughts

Observational clinical trials remind us that clinical research isn’t only about testing the next new drug. In diseases like mesothelioma, where patient numbers are relatively small, every piece of information about disease patterns, patient experiences and long-term outcomes matters.

By carefully observing and recording, researchers can generate insights that ultimately improve both treatment strategies and quality of life for patients.

About the Writer, Dr. Stephen Williams, Precision Oncology Scientist

Dr. Stephen Williams is a Precision Oncology Scientist in the Department of Pathology and Laboratory Medicine at MD Anderson Cancer Center in Houston, Texas. Dr. Williams served as a medical reviewer, guest blog writer, and medical content writer for Mesothelioma Guide since 2024. He helped the organization inform and educate patients and loved ones about cancer treatment – ensuring all content published on the Mesothelioma Guide website was accurate, concise, and clear.

Understanding Observational Clinical Trials: What They Are and Their Role in Mesothelioma Research